Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
CRBP

Updated 10/6/2026, 8:56 AM ET.

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Sale$15,683

Ben Yong

Director

2,000 shat $7.84Filed Sep 15, 4:59 PM ET
Filing
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Buy$25,036

Saxena Nishant C

Chief Business Officer

2,600 shat $9.63Filed Aug 12, 4:30 PM ETFiling
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Sale$171,396

Cohen Yuval

Chief Executive Officer, Director

17,000 shat $10.08Filed Aug 10, 4:30 PM ET
Filing
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Sale$120,971

Moran Sean F.

Chief Financial Officer

12,000 shat $10.08Filed Aug 10, 4:30 PM ET
Filing

Read from public SEC filings. Not financial advice.